1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Sartorius AG
  6. News
  7. Summary
    SRT   DE0007165607

SARTORIUS AG

(SRT)
  Report
Real-time Estimate Tradegate  -  05/18 10:10:52 am EDT
315.00 EUR   -2.33%
05/16SARTORIUS VORZUEGE : UBS takes a positive view
MD
04/26SARTORIUS VORZUEGE : Warburg Research reaffirms its Buy rating
MD
04/22SARTORIUS VORZUEGE : JP Morgan reiterates its Buy rating
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Sartorius Acquires Majority Stake in ALS Automated Lab Solutions

12/16/2021 | 07:48am EDT

By Giulia Petroni

Sartorius AG said on Thursday that it would acquire a majority stake in Germany-based laboratory technology company ALS Automated Lab Solutions GmbH for an undisclosed sum.

The pharmaceutical and laboratory-equipment supplier said it would initially buy 62.5% of ALS's shares on Jan. 3, while the rest will be bought in 2026.

ALS makes solutions for the automated analysis, selection and isolation of cells, according to the company. It currently employs around 30 people and is expected to generate sales in the high single-digit million-euro area this year, with a double-digit earnings before interest, taxes, depreciation and amortization margin.

Write to Giulia Petroni at giulia.petroni@wsj.com

(END) Dow Jones Newswires

12-16-21 0748ET

Stocks mentioned in the article
ChangeLast1st jan.
SARTORIUS AG -2.64% 314 Delayed Quote.-35.37%
SARTORIUS STEDIM BIOTECH -1.71% 298.1 Real-time Quote.-37.13%
All news about SARTORIUS AG
05/16SARTORIUS VORZUEGE : UBS takes a positive view
MD
04/26SARTORIUS VORZUEGE : Warburg Research reaffirms its Buy rating
MD
04/22SARTORIUS VORZUEGE : JP Morgan reiterates its Buy rating
MD
04/22SARTORIUS VORZUEGE : Deutsche Bank maintains a Buy rating
MD
04/22SARTORIUS VORZUEGE : Berenberg maintains a Buy rating
MD
04/21TRANSCRIPT : Sartorius Aktiengesellschaft, Q1 2022 Earnings Call, Apr 21, 2022
CI
04/21SARTORIUS : Conference Call Q1|2022 Presentation
PU
04/21SARTORIUS VORZUEGE : Gets a Buy rating from Berenberg
MD
04/21SARTORIUS VORZUEGE : UBS sticks Neutral
MD
04/21Sartorius Aktiengesellschaft Reports Earnings Results for the First Quarter Ended March..
CI
More news
Analyst Recommendations on SARTORIUS AG
More recommendations
Financials
Sales 2022 4 139 M 4 360 M 4 360 M
Net income 2022 582 M 613 M 613 M
Net Debt 2022 1 457 M 1 535 M 1 535 M
P/E ratio 2022 36,1x
Yield 2022 0,37%
Capitalization 22 881 M 24 101 M 24 101 M
EV / Sales 2022 5,88x
EV / Sales 2023 5,30x
Nbr of Employees 15 051
Free-Float 33,3%
Chart SARTORIUS AG
Duration : Period :
Sartorius AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SARTORIUS AG
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Last Close Price 322,50 €
Average target price 443,55 €
Spread / Average Target 37,5%
EPS Revisions
Managers and Directors
Joachim Kreuzburg Chief Executive Officer
Rainer Lehmann Chief Financial Officer
Lothar Kappich Chairman-Supervisory Board
Oscar-Werner Reif Head-Research & Development
Volker Niebel Head-Production, Procurement & Business Operations
Sector and Competitors
1st jan.Capi. (M$)
SARTORIUS AG-35.37%24 101
BIOTAGE AB (PUBL)-25.31%1 301
REVENIO GROUP OYJ-19.03%1 259
VAREX IMAGING CORPORATION-29.54%885
CELLAVISION AB (PUBL)4.24%815
908 DEVICES INC.-37.03%512